MUNICH RE |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 418 EUR | -0.77% |
|
+1.90% | +11.31% |
| Apr. 18 | MUNICH RE : JP Morgan reiterates its Buy rating | ZD |
| Apr. 18 | MUNICH RE : Barclays reiterates its Buy rating | ZD |
| Sales 2024 * | 63B 67.3B | Sales 2025 * | 65.22B 69.66B | Capitalization | 55.98B 59.79B |
|---|---|---|---|---|---|
| Net income 2024 * | 5.13B 5.48B | Net income 2025 * | 5.49B 5.86B | EV / Sales 2024 * | 0.91 x |
| Net Debt 2024 * | 1.14B 1.22B | Net Debt 2025 * | 1.14B 1.22B | EV / Sales 2025 * | 0.88 x |
| P/E ratio 2024 * |
10.8
x | P/E ratio 2025 * |
9.91
x | Employees | 42,812 |
| Yield 2024 * |
3.79% | Yield 2025 * |
4.04% | Free-Float | 98.63% |
More Fundamentals
* Assessed data
More news
Latest transcript on Munich Re
More press releases
| 1 day | -0.77% | ||
| 1 week | +1.90% | ||
| Current month | -7.15% | ||
| 1 month | -3.70% | ||
| 3 months | +6.56% | ||
| 6 months | +12.29% | ||
| Current year | +11.31% |
1 week
406.80
421.30
1 month
406.80453.10
Current year
374.90455.00
1 year
319.60455.00
3 years
205.45455.00
5 years
142.00455.00
10 years
140.90455.00
| Managers | Title | Age | Since |
|---|---|---|---|
Joachim Wenning
CEO | Chief Executive Officer | 59 | 90-12-31 |
| Director of Finance/CFO | 49 | 18-12-31 | |
| Chief Investment Officer | 49 | 19-03-17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Frank Fassin
BRD | Director/Board Member | 64 | 09-04-21 |
| Director/Board Member | 65 | 17-07-03 | |
| Director/Board Member | 62 | 17-01-02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 419.3 | -0.47% | 175 |
| 24-04-22 | 421.3 | +1.27% | 1,312 |
| 24-04-19 | 416 | +0.80% | 1,192 |
| 24-04-18 | 412.7 | +1.15% | 1,166 |
| 24-04-17 | 408 | -0.85% | 963 |
Delayed Quote Deutsche Boerse AG, April 23, 2024 at 03:30 am EDT
More quotes
Münchener Rückversicherungs-Gesellschaft (Munich Re) is one of the world leaders in reinsurance. Gross written premiums break down by activity as follows:
- reinsurance (70.4%): non-life reinsurance (77.2% of gross written premiums) and life and health reinsurance (22.8%);
- insurance (29.6%): life and health insurance (50% of gross premiums issued) and non-life insurance (21.2%). The remaining gross written premiums (28,8%) are from international insurance activities.
Revenues are distributed geographically as follows: Germany (30.3%), Europe (26.2%), North America (28.8%), Asia and Australasia (9.8%), Africa and the Middle East (2.7%) and Latin America (2.2%).
Sector
Reinsurance
Calendar
2024-04-24
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
418.5
EUR
Average target price
446
EUR
Spread / Average Target
+6.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.89% | 29.65B | |
| +5.45% | 18.18B | |
| +15.72% | 11.96B | |
| +5.00% | 2.07B | |
| -4.75% | 1.57B | |
| +5.60% | 967M | |
| +48.92% | 658M | |
| -7.97% | 643M | |
| +8.84% | 440M |
- Stock Market
- Equities
- MUV2 Stock
- MUV2 Stock
